Press release
The Increasing Stress Levels And Lifestyle Changes Fueling The Growth Of The Market Due To Their Impact On Emotional Health And Sleep Disruption: The Driving Engine Behind Insomnia Therapeutics Market Evolution in 2025
Insomnia Therapeutics
Insomnia Therapeutics Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market size for insomnia therapeutics has experienced robust growth. The market, which was valued at $3.03 billion in 2024, is projected to expand to $3.2 billion in 2025, registering a compound annual growth rate (CAGR) of 5.7%. The historical growth can be linked to various factors including a rise in insomnia cases, enhanced understanding of sleep disorders, an increase in the application of cognitive behavioral therapy for insomnia (CBT-I), the growth of pharmaceutical interventions, and a rise in the utilization of over-the-counter sleep aids.
How Will the Insomnia Therapeutics Market Size Evolve and Grow by 2029?
The market size for insomnia treatments is predicted to witness significant expansion in the next few years, reaching "$3.98 billion by 2029 with a compound annual growth rate (CAGR) of 5.6%. This growth during the forecasted period can be attributed to the progress in AI-powered sleep monitoring, the growing demand for tailored medicine, the increasing older population suffering from sleep issues, enhanced mental health awareness, and a burgeoning arsenal of innovative insomnia medicines. Key trends for the forecast period encompass the inclusion of digital therapeutics in insomnia management, a growing inclination for non-drug therapies, a rise in the use of wearable sleep tracking devices, the creation of advanced sleep medications, and the progression of telemedicine for managing sleep disorders.
View the full report here:
https://www.thebusinessresearchcompany.com/report/insomnia-therapeutics-global-market-report
What Drivers Are Propelling the Growth of Insomnia Therapeutics Market Forward?
The surge in stress levels and alterations in lifestyle are projected to drive the expansion of the insomnia therapeutics market. These levels of stress and lifestyle modifications pertain to psychological and behavioural changes in day-to-day responsibilities and routines, causing emotional tension and interrupting sleep cycles. The escalation in these factors is fuelled by continuous digital connection, reducing work-life separation and curtailing opportunities for genuine mental relaxation. Insomnia therapeutics play an indispensable part by delivering efficient, evidence-based treatment options that restore normal sleep cycles, decrease anxiety related to sleep, and bolster mental health in the face of contemporary stressors. For example, in May 2024, the American Psychiatric Association (APA), an organization of psychiatrists based in the US, noted an increase in the percentage of US adults feeling more anxious. This rose from 32% in 2022 to 37% in 2023 before peaking at 43% in 2024. Hence, the growth of the insomnia therapeutics market is being influenced by the rise in stress levels and lifestyle shifts.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24255&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Insomnia Therapeutics Market?
In the insomnia therapeutics market, leading businesses are prioritizing the development of progressive therapies such as dual orexin receptor antagonists (DORAs) to offer specific treatments with minimal side effects and enhanced safety measures. A dual orexin receptor antagonist (DORA) is a medication type that hampers both orexin-1 and orexin-2 receptors in the brain. This action promotes sleep by hindering the wakefulness signaling pathway used commonly to treat insomnia. For example, in June 2023, QUVIVIQ (daridorexant), a novel dual orexin receptor antagonist (DORA), was launched by Idorsia Pharmaceuticals Ltd., a pharmaceutical company based in Switzerland, to treat chronic insomnia disorder. The therapy aims to lessen nighttime wakefulness without disturbing normal sleep architecture, thereby improving sleep onset, maintenance, and daytime functioning for patients. This approval signifies a crucial progression in insomnia treatment, offering a distinctive action mechanism separate from typical sedative-hypnotics and satisfying the unaddressed need for long-term, non-addictive therapeutic options.
What Are the Key Segments in the Insomnia Therapeutics Market?
The insomnia therapeutics market covered in this report is segmented -
1) By Treatment Type: Drugs, Medical Devices
2) By Formulation: Tablets, Capsules, Liquid Solutions, Patches
3) By Route Of Administration: Oral, Intravenous, Transdermal, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinics, Wellness Centers
Subsegments:
1) By Drugs: Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists, Other Drugs
2) By Medical Devices: Cognitive Behavioral Therapy Devices (CBT-I Devices), Polysomnography Devices, Sleep Tracking Devices, Neurostimulation Devices, Light Therapy Devices
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24255&type=smp
Who Are the Key Players Shaping the Insomnia Therapeutics Market's Competitive Landscape?
Major companies operating in the insomnia therapeutics market are Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Eisai Co. Ltd., Sumitomo Pharma Co. Ltd., Aurobindo Pharma, Astellas Pharma Inc., Acadia Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Idorsia Ltd, Minerva Neurosciences, Big Health, Neurovalens, Electromedical Products International Inc., Neurim Pharmaceuticals Ltd., Innovative Neurological Devices (IND), Blake Insomnia Therapeutics Inc., Cerêve Inc.
What Geographic Markets Are Powering Growth in the Insomnia Therapeutics Market?
North America was the largest region in the insomnia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insomnia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24255
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Increasing Stress Levels And Lifestyle Changes Fueling The Growth Of The Market Due To Their Impact On Emotional Health And Sleep Disruption: The Driving Engine Behind Insomnia Therapeutics Market Evolution in 2025 here
News-ID: 4184554 • Views: …
More Releases from The Business Research Company
Rising Demand For Personalized Care Fueling The Growth Of The Market Due To Enha …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Nocturnal Enuresis Medication Market Through 2025?
The market for nocturnal enuresis drugs has seen substantial growth in the past few years. The market is projected to surge from $1.53 billion in 2024 to $1.63 billion in 2025, with a compound annual growth…
MSI-H And dMMR: A Leading Driver Behind Rising Prevalence Of Cancer Is Fueling T …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the MSI-H And dMMR Industry Market Size Be by 2025?
In the past few years, there has been an astounding surge in the market size of MSI-H and dMMR. Its estimated progression is from $6.15 billion in 2024 to $7.57 billion in 2025, with a compound annual…
Losartan Potassium Active Pharmaceutical Ingredient (API) Market Trends That Wil …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Losartan Potassium Active Pharmaceutical Ingredient (API) Market Size By 2025?
The market for the active pharmaceutical ingredient losartan potassium has been witnessing significant expansion in recent times. Projections indicate that it will increase from $1.75 billion in 2024 to $1.85 billion in 2025, exhibiting a…
Steady Expansion Forecast for Humanoid Healthcare Assistive Robot Market, Projec …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Humanoid Healare Assistive Robot Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for humanoid healare assistive robots has seen an explosive growth in the past few years. From its size of $1.06 billion in 2024, the market is predicted to expand to…
More Releases for Insomnia
Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Insomnia Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the insomnia market has been on a constant rise. From $5 billion in 2024, the market is projected to expand to $5.24 billion in 2025, marking a compound annual growth rate…
Insomnia Treatment Market: Embrace Restful Nights and Recharge Your Life with Br …
Insomnia, a common sleep disorder, affects millions of people worldwide. The condition not only disrupts the sleep-wake cycle but also affects overall health and quality of life. With the increasing prevalence of insomnia, the demand for effective treatment options has surged, driving the growth of the insomnia treatment market.
Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on to…
Insomnia - Drug Pipeline Landscape, 2023
Insomnia is a sleep disorder that is characterized by difficulty falling asleep or staying asleep. Insomnia can be caused by a variety of factors, including stress, anxiety, depression, medications, and medical conditions. Treatment for insomnia typically includes lifestyle changes, such as avoiding caffeine and establishing a regular sleep schedule, as well as cognitive behavioral therapy and, in some cases, medication.
There are two types of insomnia primary and secondary. Primary insomnia…
Insomnia - Drug Pipeline Landscape, 2022
Insomnia is a progressive, degenerative brain disorder that attacks the brain's nerve cells, or neurons, and causes them to waste away. This disease is characterized by a slow, gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ability severe enough to interfere with daily…
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom.
The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning…
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account
The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases…
